Renegade Enterprises Aggregated from Arab News

Novartis’ breast cancer drug cuts risk of death by 19 percent after six years, data shows

LONDON: Swiss drugmaker Novartis’ drug Kisqali helped extend survival for women with a form of high-risk, early-stage breast cancer, cutting their risk of death by 19 percent after six years, according to trial data pres

You are being forwarded to Arab News in a few seconds. Renegade Enterprises is a news aggregator — we credit, link, and attribute every story to its original publisher. If you are the rights holder and want this link removed, use our DMCA process.